Balsu Gida Sanayi - Public Comps and Valuation Multiples

Balsu Gida Sanayi Overview

About Balsu Gida Sanayi

Balsu Gida Sanayi Ve Ticaret AS operates in food industry. The company's product ranges from natural hazelnuts, chopped hazelnuts, roasted hazelnut kernels, blanched hazelnut kernels to hazelnut paste and hazelnut flour.

Founded

2001

HQ

Employees

n/a

Website

balsugida.com

Sectors

Food & Beverages

Financials

Last FY Revenue $416M

Last FY EBITDA $42.2M

EV

$727M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Balsu Gida Sanayi Financials

See Balsu Gida Sanayi valuation multiples based on analyst estimates

Balsu Gida Sanayi P&L

In the most recent fiscal year, Balsu Gida Sanayi reported revenue of $416M and EBITDA of $42.2M.

Balsu Gida Sanayi expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Balsu Gida Sanayi valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$416M	XXX	XXX	XXX
Gross Profit	XXX	$64.3M	XXX	XXX	XXX
Gross Margin	XXX	15%	XXX	XXX	XXX
EBITDA	XXX	$42.2M	XXX	XXX	XXX
EBITDA Margin	XXX	10%	XXX	XXX	XXX
EBIT	XXX	$42.9M	XXX	XXX	XXX
EBIT Margin	XXX	10%	XXX	XXX	XXX
Net Profit	XXX	$11.4M	XXX	XXX	XXX
Net Margin	XXX	3%	XXX	XXX	XXX
Net Debt	XXX	$190M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Balsu Gida Sanayi including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Balsu Gida Sanayi achieved $416M in revenue and $42.2M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$416M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$64.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	15.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$42.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	10.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$42.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	10.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$11.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	2.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$190M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Balsu Gida Sanayi

This financial data table provides comprehensive performance metrics for Balsu Gida Sanayi, a company based in Turkey. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Balsu Gida Sanayi reported $416M in total revenue.
Fiscal year EBITDA was $42.2M.
The company maintained a gross profit margin of 15.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 10.2%.
Net profit margin reached 2.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Balsu Gida Sanayi. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Balsu Gida Sanayi Stock Performance

Balsu Gida Sanayi has current market cap of TRY 22.8B (or $544M), and EV of TRY 30.4B (or $727M).

Market Cap Evolution

Balsu Gida Sanayi Stock Data

As of October 17, 2025, Balsu Gida Sanayi's stock price is TRY 20 (or $0).

See Balsu Gida Sanayi trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$727M	$544M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Balsu Gida Sanayi Valuation Multiples

Balsu Gida Sanayi's trades at 1.7x EV/Revenue multiple, and 17.2x EV/EBITDA.

See valuation multiples for Balsu Gida Sanayi and 15K+ public comps

Balsu Gida Sanayi Financial Valuation Multiples

As of October 17, 2025, Balsu Gida Sanayi has market cap of $544M and EV of $727M.

Equity research analysts estimate Balsu Gida Sanayi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Balsu Gida Sanayi's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$544M	XXX	$544M	XXX	XXX	XXX
EV (current)	$727M	XXX	$727M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	1.7x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	17.2x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	17.0x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	47.9x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-5.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Balsu Gida Sanayi Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Balsu Gida Sanayi Margins & Growth Rates

Balsu Gida Sanayi's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Balsu Gida Sanayi's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Balsu Gida Sanayi's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Balsu Gida Sanayi and other 15K+ public comps

Balsu Gida Sanayi Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	10%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	5%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial